49.3.4 - Clinical outcome of patients surviving more than three years after subintimal angioplasty (ID: 30270)

M. Akesson, L. Riva, K. Ivancev, P. Uher, A. Lundell, M. Malina

Topic:

Vascular

Session:

49.3 - Peripheral Angioplasty (2) (7 presentations)

2908.3 - E-MISAGO: the largest ongoing real life registry of Misago SX nitinol stent in daily use. The results of the first 1000 patients who reached primary safety endpoint at 1 month (ID: 55892)

C. Loehr, F. E. Vermassen, M. Åkesson, I. Kralj, U. Wahl, W. Taieb, P. Sebillotte, L. Kindl, G. Schmid, J. Ruef

Topic:

Peripheral vascular disease intervention

Session:

FP 2908 - PVD 3 (6 presentations)

1102.2 - Every lesion can be crossed (ID: 57512)

M. Åkesson

Topic:

Others | Peripheral vascular disease intervention

Session:

SY 1102 - Boston Scientific: TASC II vs. innovation: should practice be driven by the future or the past? (6 presentations)

P-340 - One year clinical outcomes of Misago-SX nitinol stent in the treatment of occluded lesions in superficial femoral or popliteal arteries (ID: 46088)

M. Åkesson, I. Kralj, M. Wierzgoń, S. Müller-Hülsbeck, M. Bustamante, J. Tacke, B. Koznar, L. Strindberg, W. Ritter, K. Schulte

Topic:

Peripheral vascular disease intervention

Session:

EPOS 2010 - electronic posters (446 presentations)

1305.1 - Subintimal angioplasty: tips for success (ID: 43376)

M. Akesson

Topic:

Vascular

Session:

WS 1305 - Subintimal angioplasty: tips for success (2 presentations)

506.2 - TEVAR - how I do it (ID: 44765)

M. Åkesson

Topic:

EVAR and TEVAR

Session:

WS 506 - TEVAR - how I do it (1 presentation)

3207.1 - TEVR: tips and tricks for the treatment of aneurysm, trauma and dissections (ID: 55399)

M. Åkesson

Topic:

Educ. Progr. - Vascular Intervention | EVAR and TEVAR

Session:

WS 3207 - TEVR: tips and tricks for the treatment of aneurysm, trauma and dissections (2 presentations)

1102.4 - What does my surgeon want (ID: 58154)

M. Åkesson

Topic:

Others | Peripheral vascular disease intervention

Session:

SY 1102 - Boston Scientific: TASC II vs. innovation: should practice be driven by the future or the past? (6 presentations)